Philip C. Buttery
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Observations on an Open-Label Phase 1/2 Dopamine Gene Therapy Trial (OXB-102/Axo-Lenti-PD) in People with Parkinson's Disease.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: March 20, 2026
The future of gene therapy for Parkinson's disease.
Journal: The Lancet. Neurology
Published: April 23, 2025
Deep brain stimulation is well tolerated and effective following ProSavin® gene therapy for Parkinson's disease.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: January 24, 2025
Disease-specific interventions: The use of cell and gene therapies for Parkinson disease.
Journal: Handbook of clinical neurology
Published: September 28, 2024
Blepharospasm Secondary to Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson Disease: Clinical Characteristics and Management Outcomes.
Journal: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
Published: December 20, 2023
Increased variance in second electrode accuracy during deep brain stimulation and its relationship to pneumocephalus, brain shift, and clinical outcomes: A retrospective cohort study.
Journal: Brain & spine
Published: March 06, 2022
Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We?
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: September 28, 2020
Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease.
Journal: Human gene therapy. Clinical development
Published: August 30, 2018
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial.
Journal: Lancet (London, England)
Published: January 14, 2014
Treating Parkinson's disease in the 21st century: can stem cell transplantation compete?
Journal: The Journal of comparative neurology
Published: June 09, 2013
Hypopituitarism, pulmonary infiltration and a spontaneously resolving occipital mass.
Journal: QJM : monthly journal of the Association of Physicians
Published: August 03, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026